Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease caused by lack of dystrophin, a sub-sarcolemmal protein, which leads to dramatic muscle deterioration.
Sara Vianello+8 more
doaj
Ets-2 Repressor Factor Silences Extrasynaptic Utrophin by N-Box–mediated Repression in Skeletal Muscle [PDF]
Kelly J. Perkins+9 more
openalex +1 more source
Structural and biochemical characterization of actin binding by dystrophin and utrophin [PDF]
M. Muthu, Amanda Smith
openalex +1 more source
Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping [PDF]
Aurélie Goyenvalle+6 more
openalex +1 more source
Myotendinous Junction Defects and Reduced Force Transmission in Mice that Lack α7 Integrin and Utrophin [PDF]
Jennifer V. Welser+7 more
openalex +1 more source
Molecular pathways involved in the control of contractile and metabolic properties of skeletal muscle fibers as potential therapeutic targets for Duchenne muscular dystrophy. [PDF]
Bonato A, Raparelli G, Caruso M.
europepmc +1 more source
Correction to: The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. [PDF]
europepmc +1 more source
Phenotypic features of genetically modified DMD-XKOXWT pigs. [PDF]
Okamoto K+14 more
europepmc +1 more source
Pharmacological activation of PPAR / stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice [PDF]
Pedro Miura+6 more
openalex +1 more source